Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. NBP250291G

Siglec-3/CD33 Antibody (CD33 3D6), DyLight 488, Novus Biologicals™
SDP

Catalog No. NBP250291G Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NBP250291G 0.1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NBP250291G Supplier Novus Biologicals Supplier No. NBP250291G
Only null left
Add to Cart
Add to Cart

Description

Mouse Monoclonal Antibody

Siglec-3/CD33 Monoclonal specifically detects Siglec-3/CD33 in Human samples. It is validated for ELISA.

Specifications

Antigen Siglec-3/CD33
Applications ELISA
Classification Monoclonal
Clone CD33 3D6
Conjugate DyLight 488
Dilution ELISA
Formulation 50mM Sodium Borate with 0.05% Sodium Azide
Gene Alias CD33 antigen, CD33 antigen (gp67), CD33 molecule, FLJ00391, myeloid cell surface antigen CD33, p67, sialic acid binding Ig-like lectin 3, Sialic acid-binding Ig-like lectin 3, SIGLEC-3, SIGLEC3gp67
Gene Symbols CD33
Host Species Mouse
Immunogen Siglec-3/CD33-Fc recombinant protein
Purification Method Protein A purified
Quantity 0.1 mL
Regulatory Status RUO
Research Discipline Immunology
Primary or Secondary Primary
Gene ID (Entrez) 945
Target Species Human
Content And Storage Store at 4C in the dark.
Form Purified
Isotype IgG1
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.